drugset / Trial / NCT01097707
A Study in Men With Benign Prostatic Hyperplasia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to determine whether LY500307 helps symptoms of Benign Prostatic Hyperplasia (BPH)
Timeline
- Start
- 2010-04
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ERTEBEREL | Small molecule | 1 mg | Oral |
| Subject | ERTEBEREL | Small molecule | 3 mg | Oral |
| Subject | ERTEBEREL | Small molecule | 10 mg | Oral |
| Subject | ERTEBEREL | Small molecule | 25 mg | Oral |